C WorldWide Group Holding A S lessened its position in Johnson & Johnson (NYSE:JNJ) by 10.0% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 286,147 shares of the company’s stock after selling 31,626 shares during the period. Johnson & Johnson makes up about 0.6% of C WorldWide Group Holding A S’s holdings, making the stock its 25th largest position. C WorldWide Group Holding A S’s holdings in Johnson & Johnson were worth $37,855,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of JNJ. Pachira Investments Inc. lifted its holdings in shares of Johnson & Johnson by 12.2% in the first quarter. Pachira Investments Inc. now owns 4,424 shares of the company’s stock valued at $551,000 after purchasing an additional 480 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its holdings in shares of Johnson & Johnson by 3.2% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 497,543 shares of the company’s stock valued at $61,969,000 after purchasing an additional 15,270 shares in the last quarter. Alpha Omega Wealth Management LLC lifted its holdings in shares of Johnson & Johnson by 1.4% in the first quarter. Alpha Omega Wealth Management LLC now owns 33,703 shares of the company’s stock valued at $4,198,000 after purchasing an additional 478 shares in the last quarter. Cliftonlarsonallen Wealth Advisors LLC lifted its holdings in shares of Johnson & Johnson by 0.7% in the first quarter. Cliftonlarsonallen Wealth Advisors LLC now owns 12,144 shares of the company’s stock valued at $1,513,000 after purchasing an additional 85 shares in the last quarter. Finally, Schaper Benz & Wise Investment Counsel Inc. WI lifted its holdings in shares of Johnson & Johnson by 0.5% in the first quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 114,681 shares of the company’s stock valued at $14,283,000 after purchasing an additional 544 shares in the last quarter. Institutional investors own 65.61% of the company’s stock.

A number of research firms have recently weighed in on JNJ. J P Morgan Chase & Co raised their target price on Johnson & Johnson from $140.00 to $148.00 and gave the company an “overweight” rating in a report on Wednesday, August 16th. Jefferies Group LLC set a $145.00 price target on Johnson & Johnson and gave the stock a “hold” rating in a report on Tuesday, August 15th. Vetr lowered Johnson & Johnson from a “hold” rating to a “sell” rating and set a $130.49 price target on the stock. in a report on Monday, September 18th. Stifel Nicolaus lifted their price target on Johnson & Johnson from $140.00 to $142.00 and gave the stock a “hold” rating in a report on Wednesday, October 18th. Finally, Citigroup Inc. lifted their price target on Johnson & Johnson from $140.00 to $149.00 and gave the stock a “buy” rating in a report on Monday, October 23rd. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $143.70.

Shares of Johnson & Johnson (NYSE JNJ) opened at $138.01 on Friday. The stock has a market capitalization of $368,832.31, a price-to-earnings ratio of 19.23, a price-to-earnings-growth ratio of 2.79 and a beta of 0.82. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02. Johnson & Johnson has a one year low of $109.32 and a one year high of $144.35.

Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, October 17th. The company reported $1.90 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.80 by $0.10. The firm had revenue of $19.65 billion for the quarter, compared to analyst estimates of $19.29 billion. Johnson & Johnson had a return on equity of 27.38% and a net margin of 21.28%. The business’s revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.68 earnings per share. equities research analysts predict that Johnson & Johnson will post 7.28 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 28th will be paid a $0.84 dividend. The ex-dividend date of this dividend is Monday, November 27th. This represents a $3.36 annualized dividend and a dividend yield of 2.43%. Johnson & Johnson’s payout ratio is presently 58.33%.

TRADEMARK VIOLATION WARNING: “C WorldWide Group Holding A S Trims Holdings in Johnson & Johnson (JNJ)” was posted by Watch List News and is the property of of Watch List News. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.watchlistnews.com/c-worldwide-group-holding-a-s-trims-holdings-in-johnson-johnson-jnj/1725865.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.